Research suggests that leafy greens may play a role in reducing chronic low-grade inflammation as part of broader anti-inflammatory dietary patterns, with a 2024 narrative review proposing that their antioxidant and bioactive compounds could support brain health and gut microbiota in ways relevant to mental and neurodegenerative conditions. Studies in this area consist primarily of reviews and cross-sectional observational studies rather than controlled trials, which limits the strength of causal conclusions that can be drawn. Findings are notably mixed, as one 2025 cross-sectional study examining diet and multiple sclerosis severity found a counterintuitive association between higher leafy green consumption and greater disease severity, though the study's authors themselves cautioned that this paradoxical result underscores the need for larger, prospective research before meaningful conclusions can be drawn. Overall, the current evidence base is preliminary and heterogeneous, and while leafy greens appear in many research frameworks as potentially beneficial anti-inflammatory foods, readers should be aware that the science remains unsettled and the available studies carry meaningful methodological limitations.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| An Anti-Inflammatory Diet and Its Potential Benefit for Individuals with Ment... | Review | 2024 | Supports | 100 |
| Dietary Inflammatory Score (DIS)'s and Lifestyle Inflammatory Score (LIS)'s I... | Other | 2025 | — | 95 |
| Factors influencing nurses' knowledge and competence in warfarin-drug and nut... | Other | 2025 | Neutral | 90 |
| Chemistry and multibeneficial bioactivities of carvacrol (4-isopropyl-2-methy... | Review | 2014 | Neutral | 85 |